Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The most effective method to Pick the Ideal Shrewd Bed for Your Special Rest Needs - 2These are the Fastest Italian Sports Cars
- 3Takeaways from AP’s report on potential impacts of Alaska’s proposed Ambler Access Road
- 4Instructions to Explore the Universe of Vehicle Leases
- 5The German series proving subtitles can be sexy — and wildly addictive
- 10 Natural products to Remember for Your Eating routine for a Better You
- Find the Excellence of Old style Expressive dance: Encountering the Effortlessness and Polish of Dance
- Most loved Amusement Park for Small children: Which One Do You Suggest?
- 'Peaky Blinders: The Immortal Man' teaser trailer reveals Cillian Murphy's Tommy Shelby back in action
- Select Your Definitive Pizza Decision
- Getting ready for a Mechanized World: 10 Positions That computer based intelligence Could Dominate
- Catch the moon dancing with bright star Regulus tonight
- Vote in favor of your Favored Kind of Scarf
- Nikki Glaser returns as host of the 2026 Golden Globes: Everything the comedian has said about the upcoming awards show
